Patents Assigned to ImClone System Incorporated
  • Patent number: 6852533
    Abstract: The invention is directed to a purified population of mammalian endothelial, muscle, or neural stem cells. The invention further provides methods for isolating such populations of cells; methods for using such populations of cells for treating mammals; methods for making vectors for gene therapy; and methods for carrying out gene therapy with such vectors.
    Type: Grant
    Filed: January 25, 1999
    Date of Patent: February 8, 2005
    Assignees: Cornell Research Foundation, Inc., Sloan-Kettering Institute for Cancer Research, ImClone System Incorporated
    Inventors: Shahin Rafii, Larry Witte, Malcolm A. S. Moore